Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications.
S K Tayebati1, G Marucci, C Santinelli
1University of Camerino, School of Pharmacy, Via Madonna delle Carceri, 9 62032 Camerino (MC), Italy. khosrow.tayebati@unicam.it.
Current Medicinal Chemistry
|October 30, 2015
Summary
Choline-containing phospholipids (CCPLs) are vital for cell membranes and brain function. Research suggests CCPLs, like GPC, offer neuroprotection and potential therapeutic benefits for cerebrovascular and neurodegenerative disorders.
Area of Science:
- Biochemistry
- Neuroscience
- Pharmacology
Background:
- Choline is an essential nutrient and a component of cell membrane phospholipids (PLs).
- Choline-containing phospholipids (CCPLs) include phosphatidylcholine (PC), sphingomyelin (SM), and choline alphoscerate (GPC).
- CCPLs are crucial for cell membrane integrity and cholinergic neurotransmission.
Purpose of the Study:
- To review the chemical, biological, and therapeutic properties of CCPLs.
- To analyze the effects of exogenous CCPLs and GPC treatment on brain function.
- To explore the neuroprotective potential of GPC in animal models of brain injury.
Main Methods:
- Literature review of published data on CCPLs.
- Analysis of studies on GPC's influence on brain cholinergic neurotransmission.
- Examination of neuroprotective effects of GPC in animal models of cerebrovascular injury.
Main Results:
- CCPLs are integral to cell membranes and involved in key metabolic pathways.
- GPC demonstrates neuroprotective effects and influences brain cholinergic neurotransmission.
- Published data suggest CCPLs' potential in treating cerebrovascular and neurodegenerative diseases.
Conclusions:
- CCPLs play a critical role in cellular life and cholinergic neurotransmission.
- GPC and cytidine-diphosphocholine show promise for treating cerebrovascular accident sequelae.
- Further research into novel choline derivatives is warranted for neurological disorders with cholinergic impairment.
Related Concept Videos
01:27Synthesis of Phosphatidylcholine in the ER Membrane
4.6K
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...
4.6K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.5K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.5K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
2.0K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
2.0K
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
2.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
2.0K